*Some Market data delayed by 15 mins.

Nexalin Technology, Inc. Common Stock

Symbol: NXL (NASDAQ)
1.31 ▼ (-11.49%) -0.170

Company Description:
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Key Stats
  • Today's Open: $1.47
  • Today's High: $1.505
  • Today's Low: $1.15
  • Today's Volume: 150.60K
  • Yesterday Close: $1.48
  • Yesterday High: $1.95
  • Yesterday Low: $0.791
  • Yesterday Volume: 750.11K
  • Last Min Volume: 120
  • Last Min High: $1.31
  • Last Min Low: $1.31
  • Last Min VWAP: $1.31
Company Profile
  • Name: Nexalin Technology, Inc. Common Stock
  • Website: https://www.nexalin.com
  • Listed Date: 2022-09-16
  • Location: HOUSTON, TX
  • Market Status: Active
  • CIK Number: 0001527352
  • SIC Code: 3845
  • SIC description: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
  • Market Cap: $9.82M
  • Round Lot: 100
  • Outstanding Shares: 7.44M
  • Asset Type: CS
RECENT FILINGS FOR NXL
Filing DateFiling TypeFormat
2024-04-16S-3View
2024-04-118-KView
2024-03-2710-KView
2024-03-208-KView
2024-01-17DEF 14AView
2023-11-1310-QView
2023-11-138-KView
2023-10-06DEF 14AView
2023-10-054View
2023-10-054View
2023-10-054View
2023-10-054View
2023-09-288-KView
2023-08-1010-QView
2023-06-304/AView
2023-06-304/AView
2023-06-304/AView
2023-06-303/AView
2023-06-303/AView
2023-06-028-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.